Vineet Laboratories Ltd (VINEETLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003496,
    "name": "Vineet Laborator",
    "stock_name": "Vineet Laborator",
    "full_name": "Vineet Laboratories Ltd",
    "name_url": "stocks-analysis/vineet-laborator",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "33.66",
    "chg": 1.13,
    "chgp": "3.47%",
    "dir": 1,
    "prev_price": "32.53",
    "mcapval": "65.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543298,
    "symbol": "VINEETLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE505Y01010",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "1.26 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/vineet-laborator-1003496-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Vineet Laborator falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vineet-laborator-fallingrising-3732240",
        "imagepath": "",
        "date": "2025-11-27 00:50:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Vineet Laboratories has outperformed its sector and benchmark indices in the short term, with the stock gaining 8.10% over the past week compared to the Sensex’s modest 0.50% rise. Over the last month, the stock has appreciated by 7.84%, significantly ahead of the Sensex’s 1.66% increase. This recent momentum is further underscored by the stock’s consecutive gains over two days, delivering a combined return of 10.73% in that period. On 26-Nov, the stock opened with a gap up of 2.35%, signalling strong buying interest at the start of the trading session, and touched an intraday high of ₹45.40.</p>\n<p>Technically, Vineet Laboratories is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day avera..."
      },
      {
        "title": "Why is Vineet Laborator falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vineet-laborator-fallingrising-3713385",
        "imagepath": "",
        "date": "2025-11-18 23:36:37",
        "description": "As of 18-Nov, Vineet Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 41.23, reflecting a decrease of Rs 1.07 or 2.53%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 10.27% during this period. Additionally, the stock has shown a significant underperformance compared to the sector, with a daily performance lagging by 1.91%. Over the past year, the stock has generated negative returns of 16.11%, contrasting sharply with the Sensex, which has increased by 9.48%. The company's weak long-term fundamentals, highlighted by a staggering -230.87% CAGR growth in operating profits over the last five years and a high Debt to EBITDA ratio of 10.01 times, further contribute to the negative sentiment surrounding the stock. The promoters' reduced stake by 13.37% in the last quarter also signals a lack of confidence in th..."
      },
      {
        "title": "Why is Vineet Laborator falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-vineet-laborator-fallingrising-3702743",
        "imagepath": "",
        "date": "2025-11-14 23:31:34",
        "description": "As of 14-Nov, Vineet Laboratories Ltd is experiencing a decline in its stock price, currently at 43.43, which reflects a decrease of 0.39 or 0.89%. The stock has been underperforming, having fallen consecutively for the last two days with a total return of -5.48% during this period. Additionally, the stock's performance today has underperformed its sector by 1.26%. In terms of returns compared to benchmarks, the stock has shown a significant decline of 30.34% year-to-date and 22.45% over the past year, while the Sensex has increased by 8.22% and 9.00% respectively. The stock's delivery volume has also decreased by 7.37% against the 5-day average, indicating falling investor participation.\n\nBroader Market Context: In the short term, Vineet Laboratories Ltd has underperformed compared to the Sensex, which has gained 1.62% over the past week while the stock has dropped by 5.34%. This stark contrast highlights ..."
      },
      {
        "title": "How has been the historical performance of Vineet Laborator?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-vineet-laborator-3683733",
        "imagepath": "",
        "date": "2025-11-09 22:48:55",
        "description": "Answer:\nThe historical performance of Vineet Laborator shows a significant decline in key financial metrics over the past few years, culminating in a challenging fiscal year ending March 2025.\n\nBreakdown:\nVineet Laborator's net sales have decreased from 243.48 Cr in March 2021 to just 75.00 Cr in March 2025, reflecting a downward trend in revenue. The total operating income followed a similar pattern, dropping from 243.48 Cr in March 2021 to 75.00 Cr in March 2025. The company's total expenditure, excluding depreciation, also decreased from 235.33 Cr in March 2021 to 91.28 Cr in March 2025, yet the operating profit (PBDIT) turned negative, showing a loss of 16.28 Cr in March 2025 compared to a profit of 8.15 Cr in March 2021. This resulted in a profit before tax of -20.78 Cr in March 2025, down from 4.06 Cr in March 2021, and a profit after tax of -20.19 Cr, contrasting with a profit of 1.78 Cr in March 202..."
      },
      {
        "title": "Are Vineet Laborator latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-vineet-laborator-latest-results-good-or-bad-3683340",
        "imagepath": "",
        "date": "2025-11-09 19:16:08",
        "description": "The latest financial results for Vineet Laboratories present a mixed picture, highlighting both operational challenges and some positive developments. In the second quarter of FY26, the company reported a net profit of ₹0.40 crores, a notable turnaround from a loss of ₹0.87 crores in the previous quarter. This improvement in profitability is encouraging; however, it comes against a backdrop of declining revenues, with net sales of ₹17.42 crores reflecting an 8.12% decrease year-on-year.\n\nThe operating margin showed significant improvement, rising to 18.25% from 4.30% in the prior quarter, indicating enhanced operational efficiency. Additionally, the profit after tax (PAT) margin also improved to 2.30%, up from a negative margin in the previous quarter. These margin expansions suggest that cost management strategies may be yielding results, although they are primarily driven by cost compression rather than r..."
      },
      {
        "title": "Vineet Laboratories Q2 FY26: Profitability Returns But Revenue Concerns Persist",
        "link": "https://www.marketsmojo.com/news/result-analysis/vineet-laboratories-q2-fy26-profitability-returns-but-revenue-concerns-persist-3682544",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VineetLaborator_quaterlyResult_3682544.png",
        "date": "2025-11-08 20:03:24",
        "description": "Vineet Laboratories Ltd., a micro-cap pharmaceutical intermediates manufacturer, posted a net profit of ₹0.40 crores in Q2 FY26, marking a dramatic turnaround from the ₹0.87 crores loss recorded in the previous quarter. However, the profitability recovery was overshadowed by persistent revenue challenges, with net sales declining 8.12% year-on-year to ₹17.42 crores, raising questions about the sustainability of this turnaround."
      }
    ],
    "total": 269,
    "sid": "1003496",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/vineet-laboratories-1003496"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "14-Jan-2026",
      "details": "We are hereby submitting the copies of the Addendum to the Letter of Offer dated December 17 2025 published today in the following newspapers: 1. Financial Express (English National Daily Newspaper with wide circulation) 2. Jansatta (Hindi National Daily Newspaper with wide circulation) 3. Nava Telangana (Telugu daily newspaper with wide circulation telugu being the regional language of Telangana where our registered office is situated.)",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-Jan-2026",
      "details": "We are hereby submitting the Newspaper publication made in Financial Express and Nava Telangana regarding the notice of Extra-Ordinary General Meeting of the Company to be held on February 07 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Meeting Updates",
      "datetime": "13-Jan-2026",
      "details": "The Rights Issue Committee of the Board of Directors in its meeting held on January 13 2026 has decided to extend the Last date for On Market Renunciation and the Issue Closing date for the benefit of the Investors. We are hereby submitting the revised dates.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Vineet Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 22",
          "dt": "2022-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Vineet Laborator falling/rising?

2025-11-27 00:50:45

Recent Price Movement and Market Context Vineet Laboratories has outperformed its sector and benchmark indices in the short term, with the stock gaining 8.10% over the past week compared to the Sensex’s modest 0.50% rise. Over the last month, the stock has appreciated by 7.84%, significantly ahead of the Sensex’s 1.66% increase. This recent momentum is further underscored by the stock’s consecutive gains over two days, delivering a combined return of 10.73% in that period. On 26-Nov, the stock opened with a gap up of 2.35%, signalling strong buying interest at the start of the trading session, and touched an intraday high of ₹45.40. Technically, Vineet Laboratories is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day avera...

Why is Vineet Laborator falling/rising?

2025-11-18 23:36:37

As of 18-Nov, Vineet Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 41.23, reflecting a decrease of Rs 1.07 or 2.53%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 10.27% during this period. Additionally, the stock has shown a significant underperformance compared to the sector, with a daily performance lagging by 1.91%. Over the past year, the stock has generated negative returns of 16.11%, contrasting sharply with the Sensex, which has increased by 9.48%. The company's weak long-term fundamentals, highlighted by a staggering -230.87% CAGR growth in operating profits over the last five years and a high Debt to EBITDA ratio of 10.01 times, further contribute to the negative sentiment surrounding the stock. The promoters' reduced stake by 13.37% in the last quarter also signals a lack of confidence in th...

Why is Vineet Laborator falling/rising?

2025-11-14 23:31:34

As of 14-Nov, Vineet Laboratories Ltd is experiencing a decline in its stock price, currently at 43.43, which reflects a decrease of 0.39 or 0.89%. The stock has been underperforming, having fallen consecutively for the last two days with a total return of -5.48% during this period. Additionally, the stock's performance today has underperformed its sector by 1.26%. In terms of returns compared to benchmarks, the stock has shown a significant decline of 30.34% year-to-date and 22.45% over the past year, while the Sensex has increased by 8.22% and 9.00% respectively. The stock's delivery volume has also decreased by 7.37% against the 5-day average, indicating falling investor participation. Broader Market Context: In the short term, Vineet Laboratories Ltd has underperformed compared to the Sensex, which has gained 1.62% over the past week while the stock has dropped by 5.34%. This stark contrast highlights ...

How has been the historical performance of Vineet Laborator?

2025-11-09 22:48:55

Answer: The historical performance of Vineet Laborator shows a significant decline in key financial metrics over the past few years, culminating in a challenging fiscal year ending March 2025. Breakdown: Vineet Laborator's net sales have decreased from 243.48 Cr in March 2021 to just 75.00 Cr in March 2025, reflecting a downward trend in revenue. The total operating income followed a similar pattern, dropping from 243.48 Cr in March 2021 to 75.00 Cr in March 2025. The company's total expenditure, excluding depreciation, also decreased from 235.33 Cr in March 2021 to 91.28 Cr in March 2025, yet the operating profit (PBDIT) turned negative, showing a loss of 16.28 Cr in March 2025 compared to a profit of 8.15 Cr in March 2021. This resulted in a profit before tax of -20.78 Cr in March 2025, down from 4.06 Cr in March 2021, and a profit after tax of -20.19 Cr, contrasting with a profit of 1.78 Cr in March 202...

Are Vineet Laborator latest results good or bad?

2025-11-09 19:16:08

The latest financial results for Vineet Laboratories present a mixed picture, highlighting both operational challenges and some positive developments. In the second quarter of FY26, the company reported a net profit of ₹0.40 crores, a notable turnaround from a loss of ₹0.87 crores in the previous quarter. This improvement in profitability is encouraging; however, it comes against a backdrop of declining revenues, with net sales of ₹17.42 crores reflecting an 8.12% decrease year-on-year. The operating margin showed significant improvement, rising to 18.25% from 4.30% in the prior quarter, indicating enhanced operational efficiency. Additionally, the profit after tax (PAT) margin also improved to 2.30%, up from a negative margin in the previous quarter. These margin expansions suggest that cost management strategies may be yielding results, although they are primarily driven by cost compression rather than r...

Vineet Laboratories Q2 FY26: Profitability Returns But Revenue Concerns Persist

2025-11-08 20:03:24

Vineet Laboratories Ltd., a micro-cap pharmaceutical intermediates manufacturer, posted a net profit of ₹0.40 crores in Q2 FY26, marking a dramatic turnaround from the ₹0.87 crores loss recorded in the previous quarter. However, the profitability recovery was overshadowed by persistent revenue challenges, with net sales declining 8.12% year-on-year to ₹17.42 crores, raising questions about the sustainability of this turnaround.

View All News